![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
Abstract
A group of new piperazine and piperidine compounds, salts thereof and processes for their preparation are claimed. These new compounds are stated to show high affinity for both the serotonin 5-HT1A and the dopamine D2 receptors. They are stated to be efficacious for the treatment of disease of the central nervous system, for example, schizophrenia, anxiety and depression. Five different synthesis are presented, 50 compounds are exemplified but no products are especially claimed.